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Effectiveness of an electronic cognitive aid in patients
with acquired brain injury: A multicentre randomised
parallel-group study
E.A. De Joode, C.M. Van Heugten, F.R.J. Verhey, and
M.P.J. Van Boxtel
School for Mental Health and Neuroscience, Maastricht University,
Maastricht, The Netherlands
The objective of the study was to examine the effectiveness of a customised
personal digital assistant (PDA) as a cognitive aid for people with acquired
brain injury, using a randomised parallel-group study. The participants were
34 patients with acquired brain injury in a cognitive rehabilitation setting.
The experimental group used a customised PDA, while the control group
received care-as-usual (paper-and-pencil aids). Measurements were conducted
at baseline (T0), after 8 hours of training (T1), after 16 hours of training (T2),
and at 5-month follow-up (T3). The main outcome was the attainment of indi-
vidualised goals. Both groups showed a significant increase in goal attainment
(GAS) (p , .001). There were no significant differences between the groups at
T1 or T2 on any of the other outcome measures. It was concluded that the
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customised PDA was as effective as paper-and-pencil aids, and may therefore
serve as a useful alternative when choosing the optimal rehabilitation strategy
for a patient.
Keywords: Assistive technology; Personal digital assistant; Acquired brain
injury; Cognitive rehabilitation; Randomised controlled trial.
INTRODUCTION
Memory, attention and executive functioning are frequently impaired in patients
with acquired brain injury (ABI), leading to difficulties in everyday life (Scholte
Op Reimer, 1999; Sundet, Finset, & Reinvang, 1988). Such cognitive deficits
have been reported in a high percentage of people with hypoxic encephalopathy
(Bigler & Alfano, 1988; Caine & Watson, 2000), lacunar infarcts (Van Zand-
voort, De Haan, Van Gijn, & Kappelle, 2003), traumatic brain injury (Van der
Naalt, Van Zomeren, Sluiter, & Minderhoud, 1999), and stroke. For example,
a substantial percentage of stroke patients reported impairments of memory
(20%), processing speed (50%) and attention (46%) (Rasquin, Verhey, Lous-
berg, Winkens, & Lodder, 2002). Such deficits can continue to interfere with
daily life functioning even many years after the injury (Barker-Collo, Feigin,
Parag, Lawes, & Senior, 2010; Hochstenbach, Den Otter, & Mulder, 2003;
Patel, Coshall, Rudd, & Wolfe, 2003; Van Heugten et al., 2000).
Cognitive impairments greatly affect the functioning of patients and also lead
to strain, distress, depression and a decreased quality of life for their informal
caregivers (Scholte op Reimer, de Haan, Rijnders, & Limburg, 1998; Thommes-
sen, Wyller, Bautz-Holter, & Laake, 2001; Van den Heuvel, 2002; Visser-Meily,
Van Heugten, Post, Schepers, & Lindeman, 2005).
Cognitive rehabilitation following brain injury is aimed at managing, redu-
cing and compensating for the cognitive deficits (Carney et al., 1999; Cicer-
one et al., 2000; Van Heugten, 2001; Wilson, 1997; Wilson, Emslie, Quirk, &
Evans, 2001). One of the possible therapeutic strategies in cognitive rehabi-
litation is the use of assistive technology (AT) to compensate for cognitive
impairments.
The use of AT in the form of personal digital assistants (PDAs) has not yet
been systematically implemented in cognitive rehabilitation. The only con-
trolled study on the use of PDAs in patients with ABI was published recently,
and reported improved timely task completion by patients with TBI (Dowds
et al., 2011). The majority of other observations made to date came from
single case studies or small, uncontrolled trials (De Joode, Van Heugten,
Verhey, & Van Boxtel, 2010). Nevertheless, promising results have been
reported, such as improved self-rated performance of everyday life tasks
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(Gentry, Wallace, Kvarfordt, & Lynch, 2008) and enhancement of indepen-
dent behaviour in daily life through the use of electronic devices (Depompei
et al., 2008). The efficacy of other types of AT devices has also been studied.
An example is the Neuropage, a paging system to compensate for memory
and planning deficits in ABI patients. A randomised crossover trial (Wilson
et al., 2001) showed that patients were able to learn how to use the Neuropage
device and were significantly more successful when using the pager than their
counterparts in the control group in terms of carrying out everyday activities
such as self-care, self-medication and keeping appointments.
The potential benefit of AT devices for cognitive rehabilitation is,
however, not evident for all patients. Certain patient variables should be con-
sidered before AT devices or PDAs are used in cognitive rehabilitation. For
instance, a PDA may be less appropriate for patients with severely impaired
cognitive abilities, who may be unable to learn how to use a PDA or how to
deal with unexpected responses of the software, and who do not have the
ability to develop effective problem-solving strategies. Previous experience
with AT devices by clinician and patient can also be considered a determinant
of a positive attitude towards AT (De Joode et al., 2011; De Joode, Van
Boxtel, Verhey, & Van Heugten, 2012; Hart, Buchhofer, & Vaccaro, 2004;
Hart, O’Neil-Pirozzi, & Morita, 2003).
The most important potential benefits for ABI patients are memory support
and task management, as these could strengthen their autonomy and increase
their quality of life. Also, PDAs can store large amounts of information rel-
evant for the user’s daily routines, information which may be accessed at
all times, making patients less dependent on extraneous information sources.
As stated above, despite these potential benefits of AT to support cognitive
functioning, no controlled experimental studies have been conducted with
PDAs in patients with brain injury, with the exception of the study by Dowds
et al. (2011). The aim of the present study was therefore to compare the
effects of a customised PDA with those of paper-and-pencil methods (such as
notebooks and diaries) in terms of everyday memory, planning abilities, daily
life functioning and quality of life in people with ABI. We also examined if
the use of a cognitive aid could reduce the burden perceived by the patients’




A multi-centre randomised parallel-group trial was undertaken to study the
effectiveness of a customised PDA. The experimental group was trained in
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the use of the PDA, while the control group received care-as-usual, involving
the use of paper-and-pencil aids.
After the selection of participants for the study, baseline measurements
were administered (T0) and target behaviours were defined. To minimise
practice effects on the verbal memory test (VVLT; see below), a dual baseline
assessment was administered within two weeks. This was followed by the
training course, which had a total duration of 16 hours. Outcome measure-
ments were administered after 8 hours of training (T1) and after 16 hours
of training (T2). Follow-up measurements took place 4–6 months after the
end of the intervention period (T3).
Participant inclusion
Seven rehabilitation centres throughout The Netherlands participated in the
study. The authors contacted 12 centres with the request to participate.
Centres were included if they were willing and able to invest sufficient
time and effort in the study. The therapists who provided the PDA training
course in each centre received at least eight hours of instruction from the
first author (EdJ) on how to use the PDA and its assistive software and
how to train the patients (see below).
Patients were recruited through the participating rehabilitation centres
between September 2008 and September 2010. During this inclusion
period, clinicians were asked to evaluate each patient who was eligible for
cognitive training to see whether they would be suitable for participation in
the study. All of these patients were receiving care as inpatients or outpatients
at the time of study. They all had cognitive deficits, as established by their
rehabilitation physician or psychologist and had been referred to the rehabi-
litation centre for cognitive rehabilitation therapy.
Inclusion criteria for patients were: (1) a diagnosis of ABI, (2) age between
18 and 75 years, (3) sufficient comprehension of Dutch, (4) experiencing pro-
blems in daily life functioning as a consequence of their brain damage,
according to the clinical judgement of the rehabilitation physician and/or
psychologist, and (5) a clinical judgement by the rehabilitation specialist
that the use of external cognitive aids could be beneficial to the patient
(i.e., sufficient level of awareness and cognitive functioning). Exclusion cri-
teria for patients were: (1) visual or manual difficulties incompatible with
normal PDA use, (2) severe psychiatric comorbidity, and (3) a progressive
neurological disorder.
Inclusion criteria for informal caregivers of patients were: a close relation-
ship with the patient; age between 18 and 75 years; and sufficient proficiency
in Dutch to read and understand the questionnaires.
The standing medical ethics committee of Maastricht University Medical
Centre reviewed the research protocol and the possible burden for
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participants, and approved the study. All patients and caregivers gave their
informed consent. The research protocol can be obtained from the corre-
sponding author.
Customised PDA
In order to offer ABI patients the greatest possible benefit from using a PDA,
we screened commercially available devices for convenience and adaptability
to the patients’ individual needs and wishes. After reviewing and comparing
several software options such as Handi (Abilia, 2011) and ISAAC (Gorman,
Dayle, Hood, & Rumrell, 2003) we opted for the Planning and Execution
Assistant and Trainer (PEAT) software (Levinson, 1997) for the current
study. The PEAT software was developed for individuals with cognitive
impairments. It provides a reminder function and supports enhanced flexi-
bility in the planning of appointments. A “floating task” function allows auto-
matic planning of the specific timing of tasks, as PEAT makes sure the user is
not double booked: the software will schedule a task when there is enough
time available, and the task is shifted to another time slot if another event
interferes. This feature is important to patients with brain injury, who often
have difficulties planning, organising and rescheduling daily activities. A
“wait button” helps the user to deal with deviations from normal routine, post-
poning the beginning or ending of a task. Furthermore, users have control
over the way they are cued at the beginning and/or end of a task. Each func-
tion is customisable to fit the specific needs of each participant using the
device. The PEAT software offers the care provider complete control to
limit or expand its functionality during the course of the training, based on
the progress made by the patient.
There are four main modules in PEAT: cue card, diary, notes section and
names section. The cue card shows the current task and the next task, in order
to remind the users of current and upcoming events. The diary shows the sche-
dule in a day, week or month view, and users can add or change appointments
or to-do tasks. The notes section allows users to take written or voice notes
and to link these directly to the relevant appointment or task in the diary.
The names section can be used to store contact information, which can also
be linked to tasks in the diary. Users are always reminded of the start and
end of a task.
The authors translated the software into Dutch in close collaboration with
the PEAT developers. For the present study, PEAT was installed on Hewlett-
Packard iPAQ HP114 devices, equipped with the Windows Mobile 6 operat-
ing system. The PEAT software completely took over the control of the PDA,
and users could not switch to the Windows environment, thus ensuring that
the user interface was standardised for all patients, and to avoid confusion.
Patients received the customised PDA at the start of the training course and
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were encouraged to use it as much as possible in order to integrate its use into
their daily routines, both at the rehabilitation centre and at home. Patients
used the PDA until the post-treatment measurement (T2, after 16 hours of
training) had been conducted. At this time, patients in both conditions had
the opportunity to buy the customised PDA at greatly reduced price. Patients
in the PDA group who did not want to continue using the PDA were advised
by their therapist about using another cognitive aid. In some cases, the thera-
pist was able to offer their patient a PDA that was either sponsored by the
rehabilitation centre or reimbursed by their personal health insurer.
Intervention procedure
Experimental condition. In the experimental group, “care-as-usual” (nor-
mally “paper-and-pencil” diary training) was replaced by PDA training with
PEAT. The customised PDA was used to compensate for various cognitive dys-
functions. Memory function was supported by the reminders offered by the PDA,
for example, to lock the door before going to bed, lock the door when leaving,
take keys when leaving, take out clothes for the morning, make a shopping
list, or take medication. Planning and organisation could be supported by plan-
ning a busy day in advance, or by using a to-do list. Initiative and attention
could also be supported, e.g., through a signal prompting the user to focus atten-
tion on an activity, or to start or end a particular activity after a certain period.
Finally, predefined scripts could be used to guide the user through several
steps of an activity. For example, doing the laundry can be divided into several
steps: sort clothes, put them in the washing machine, set the programme, add
detergent, start the programme and dry the clothes. Since users could schedule
these steps as one task, while the software made sure that every step of the
script was performed on time, patients could independently organise these
more complex tasks as well.
A total of 16 hours of PEAT training was provided for the participants by
therapists at the various rehabilitation centres, according to their centre’s
usual procedure. All training courses followed the same initial procedure,
based on a predefined protocol, to teach patients how to use the device and
what information could and should be entered into it. (The training protocol
can be obtained from the first author.) This initial training procedure took
between two and six half-hour sessions. The content of the remainder of
the training course was tailored to the patients’ specific needs with respect
to the use of the customised PDA. The frequency of training sessions
varied between two times a week and two times a month. In most cases,
the participants received 30–60 minutes of training each week. The fre-
quency and intensity of the training sessions depended on routine procedures
at the rehabilitation centre and the needs of each individual patient. Thus, only
the total duration of the training was controlled by the researchers.
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Control condition. The control group did not use a PDA with PEAT, but
instead received “care-as-usual”, aimed at learning skills and strategies to
support memory, planning and organisation. Most centres provided training
in the use of standard paper-and-pencil aids, such as notebooks and diaries.
Although the “care-as-usual” that was offered differed to some extent
between centres, most centres gave patients diary training, in which they
learned to use a diary, that is, what kind of information they should record,
how to structure their day and week and how to integrate diary use in their
daily routine. Just as in the experimental condition, the training focused on
the specific needs of each patient, although this was limited to the use of a
paper diary in the control condition.
The participants in the control condition also received a fixed number of 16
hours of training, which is the average duration for this kind of cognitive
training in The Netherlands. The training was always provided by the same
professional who also took part in the experimental intervention. The fre-
quency and intensity of the training were the same as in the experimental
group.
Mobile phones are increasingly used as prompting devices in cognitive
rehabilitation in The Netherlands, and one of the patients in the control
group did indeed use a mobile phone as an additional aid, in combination
with a paper diary. However, the therapists did not train the control group
patients in the use of the mobile phone.
Outcome measures
Main outcome measures
Goal Attainment Scaling (GAS). GAS was the primary outcome
measure; it provides an overall outcome assessment by setting individual
goals and assessing the level of attainment of these goals after a certain
period (Kiresuk & Sherman, 1968). GAS thus enables the use of individua-
lised patient goals as well as being a standardised measurement method. It
has been used successfully in studies that included patients with ABI
(Bouwens, Van Heugten, & Verhey, 2009). A summary formula is used
to calculate the extent to which patients’ goals are achieved (Rockwood,
Joyce, & Stolee, 1997). The hypothetical mean GAS score at the time of
evaluation is 50 (SD ¼ 10), which means that if the post-treatment
outcome measurement is between 40 and 60 points, all predefined goals
have been met as expected at evaluation. Consistently high or low evalu-
ation scores at the end of an intervention indicate that goals were too
easy (score . 50), or too difficult to attain (score , 50) (Gordon, Powell,
& Rockwood, 1999).
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Cognitive Failure Questionnaire (CFQ). In this self-report questionnaire
patients rate the number of mistakes they make per day due to cognitive def-
icits, such as forgetting names, or problems of attention and concentration
(Ponds, Van Boxtel, & Jolles, 2006). The CFQ consists of 25 questions,
and patients can rate the frequency of their problems on a 5-point scale
(“never” to “very often”); the total scoring range is 0–100, a higher score
denoting more everyday cognitive failures.
Frenchay Activities Index (FAI). The FAI assesses a patient’s level of
instrumental and social activities (Schuling, de Haan, Limburg, & Groenier,
1993). The questionnaire consists of 15 items and the score ranges from 0 to
45, a higher score indicating better function.
General perceived self-efficacy scale (GSES). The GSES is a 10-item
psychometric scale designed to assess the ability to cope with a variety of
life demands (Luszczynska, Scholz, & Schwarzer, 2005). It explicitly refers
to personal agency, i.e., the belief that one is responsible for successful per-
sonal outcomes. The scoring range is 10 to 40, a higher score reflecting a
higher self-efficacy level.
Utrecht Coping List (UCL). This questionnaire has been developed to
measure the different characteristics of coping style on a 4-point scale (ranging
from 1 ¼ “never”, to 4 ¼ “very often”) and consists of 47 items and seven sub-
scales (Schreurs et al., 1993). The subscales represent different coping styles:
active approach, palliative reaction, avoidance, seeking social support, passive
reaction pattern, expression of emotions, and reassuring thoughts.
Satisfaction with cognitive aid
The participants’ satisfaction with the PDA as a cognitive aid was assessed
by determining the percentage of persons in the PEAT intervention group
expressing the wish to continue using the PDA after the 16-week training
period (T2).
Secondary outcome measures
Centre for Epidemiologic Studies Depression Scale (CES-D). The CES-D
is a screening test to identify depressive symptoms (Roberts & Vernon, 1983).
The questionnaire consists of 20 items and participants can answer on a 4-point
scale, ranging from “rarely or none of the time” to “most or all of the time”. The
scale ranges from 0 to 60, and higher scores indicate more depressive
symptoms.
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MOS Short Form health survey (SF-36). The SF-36 was constructed to
assess health status and health-related quality of life (QoL) (Ware & Sher-
bourne, 1992). It contains 36 items, which may be clustered into two dimen-
sions: physical and mental functioning. The total score for each dimension
ranges from 0 to 100, with higher values representing better functioning.
Life Satisfaction Questionnaire (LISAT-9). The LISAT questionnaire
assesses a person’s satisfaction about important life domains (Carlsson &
Hamrin, 1996). It consists of nine items, each scored on a 6-point scale
(range: 1 ¼ “very dissatisfied” to 6 ¼ “very satisfied”). The total score
ranges from 6 to 54, with higher values representing greater satisfaction.
Caregiver outcome measures
Caregivers also completed the CES-D, SF-36 and LISAT-9, as well as the
Caregiver Strain Index.
Caregiver Strain Index (CSI). The CSI (13-item, range 0–13) measures
strain related to care provision (Robinson, 1983) for the following major
domains: employment, financial, physical, social and time. Positive responses
to seven or more items on the index indicate a higher level of strain.
Cognitive assessment
Although no improvement in neuropsychological test performance was
expected, a pre- and post-intervention assessment of basic cognitive abilities
was performed.
Episodic verbal memory was tested with the Visual Verbal Learning Test
(VVLT; Van der Elst, Van Boxtel, Van Breukelen, & Jolles, 2005), a Dutch
adaptation of the Rey VVLT (Lezak, Howieson, & Loring, 2004). The total
score for all five learning trials and the delayed recall score were recorded.
Executive functioning was tested with the Stroop Color–Word Test
(SCWT; Van der Elst, Van Boxtel, Van Breukelen, & Jolles, 2006b), asses-
sing the time needed to complete card III as well as the time difference
between card III and card II. In addition, the participants completed the
Concept Shifting Test (CST; Van der Elst, Van Boxtel, Van Breukelen, &
Jolles, 2006a). This is an equivalent of the Trail Making Test that measures
concept shifting and executive functioning. The time difference between
Part C (numbers and letters) and Part B (only letters) was calculated.
Lastly, participants performed the Letter Digit Substitution Test (LDST;
Van der Elst, Van Boxtel, Van Breukelen, & Jolles, 2006c), a test of psycho-
motor speed and working memory. The number of numbers correctly copied
within 90 seconds was recorded.
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A cognitive domain was considered as being impaired if one or more
scores of the neuropsychological tests for this domain were below cut-off
(i.e., . 1.5 SD below the age- and education-corrected mean).
Procedure
After participants and their informal caregivers had been recruited, they were
asked to give informed consent. Baseline measurements included demo-
graphic variables (i.e., gender, age, education and living situation), injury-
related characteristics (i.e., type of brain damage, time since injury and side
of brain lesion), and cognitive assessment. After the first baseline measure-
ment, the patient and the informal caregiver completed the outcome question-
naires at home, and returned them at the second baseline measurement. This
was also the occasion when the dual baseline measurement for the VVLT was
administered and the target behaviours interview was held in order to set the
goals for the GAS procedure. This was done by the first author in close con-
sultation with the patient, and if necessary, in the presence of the informal
caregiver.
Goals had to be both realistic and attainable for patients receiving cogni-
tive rehabilitation and were not specific to treatment condition, as they
were set before randomisation took place. Each patient set a minimum of
three goals, and five levels of achievement were specified for each goal.
This level ranged from functioning at a level worse than before (score: –2)
to achieving the expected outcome (score: 0), and to achieving a higher
than expected level of functioning (score: +2). For example, one patient
wanted to improve the completion of tasks, instead of doing more tasks
without being able to complete them. Thus, five levels of achievement
were defined, ranging from completing none or only one out of five daily
tasks to completing all five tasks every day.
After the two baseline measurements, the patients were randomised to the two
groups, using block-wise randomisation with a block size of four, i.e., two par-
ticipants to the experimental group and two to the control group. Randomisation
was done separately for each participating centre. For each centre, four opaque
sealed envelopes (a “block”) were set aside, each containing a sheet that coded
for group assignment. These envelopes were taken to a participant for the ran-
domisation procedure. The participant then chose an envelope in the presence
of the researcher and sometimes also the caregiver. The remaining envelopes
were taken back to the university and were kept in a locked cabinet until the
next participant from this centre was enrolled in the study. Once all four envel-
opes had been used, a new set of four envelopes was prepared. Blinding of treat-
ment was not possible, due to the nature of the intervention. Outcome
measurements were administered by the researcher and were therefore not
blinded either. Figure 1 shows the measurement procedure.
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Training started within two weeks after the second baseline assessment at
T0. The mid-term measurement was administered after 8 hours of training
(T1). The questionnaires for this measurement were sent by post. Post-treat-
ment assessment took place after 16 hours of training (T2). The therapists
informed the researchers when this number of training hours had been
achieved. The patient was subsequently contacted to schedule an appointment
for the measurements. These included cognitive assessment, scoring the level
of attainment for the GAS goals in a second target behaviours interview and
completing the questionnaires. The final follow-up assessment was adminis-
tered 4–6 months after the end of the treatment (T3), and questionnaires were
again sent to the participants by post. The mean (SD) time between T0 and T1
was 3.3 months (1.7), the time between T1 and T2 was 4.8 months (3.0), and
the time between T2 and T3 was 7.1 months (3.3).
Statistical analyses
Descriptive statistics, including t-tests and chi-squared tests, were used to
compare the demographic variables, injury-related characteristics and neu-
ropsychological functioning of the two groups at baseline.
Analyses were based on the intention-to-treat principle, which means that
patients were analysed according to the group to which they were allocated,
irrespective of actual treatment. In addition, per-protocol analyses were per-
formed because some patients stopped using PEAT during the intervention
period. Differences in the GAS outcome measurements between the groups
at T2 were tested using an independent samples t-test. In addition, we
tested the differences in GAS scores between T0 and T2 in each group sep-
arately, using a post-hoc paired samples t-test.
Other outcome measurements were evaluated using repeated measures
analysis of variance (T1 vs. T2). The effect of treatment was tested using
only the T1 and T2 measurements, since the numbers of patients in the analyses
at T3 were limited and some patients had stopped using PEAT while others
continued using it, so it was not possible to form subgroups with respect to
the effect of the intervention. Group membership was treated in the model as
a between-subjects factor, and time of measurement as a within-subject factor.
Statistical analyses were performed with the SPSS statistical software
(version 19 for Mac OSX), with alpha level set at .05 for all analyses.
RESULTS
Participants
The seven participating rehabilitation centres referred 45 patients for partici-
pation, 40 of whom were included in the study and randomly allocated to a
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treatment group (Figure 2). In the end, measurements were available for 21
patients in the experimental group and 13 in the control group.
Table 1 shows the patient characteristics, which were comparable
between the groups at baseline. Mean time since injury was 27
months shorter in the experimental group than in the control group,
but this difference was not significant due to the large variability
(p ..05).
Table 2 shows the level of neuropsychological functioning at T0 and T2.
Significant improvements over time in the VVLT delayed recall and LDST
scores were found in the experimental group. However, no differences
between the groups were observed at T0 or T2 (p ..05).
Figure 2. Flow chart of participants in the trial.
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Treatment effects
GAS
Figure 3 shows the mean GAS scores at T0 and T2 for both groups. One
participant in the control group was unable to formulate goals for the GAS,
most likely due to a lack of insight. Both groups showed improvement in
the attainment of set goals between T0 and T2: the experimental group
showed a mean increase of 45.2 (SD ¼ 32.8) points, t(20) ¼ 6.31, p ,
.001, while the control group showed a mean increase of 36.7 points (SD
¼ 15.6), t(11) ¼ 8.16, p , .001. However, scores did not differ significantly
between the groups at T2 (p . .05). Since three participants stopped using
PEAT and used a standard aid instead, we also performed per-protocol ana-
lyses. These analyses showed results similar to those of the intention-to-
treat analyses.
Other outcome measures
Table 3 shows the mean scores on the other outcome measures for both
treatment groups. Our repeated measures analyses found none of these
outcome measures to differ significantly between the groups at T1 or T2 (p
. .05). In the per-protocol analyses, however, the results showed an inter-
action effect between time of measurement and group membership for one
secondary outcome measurement: the CES-D. Participants in the experimen-
tal group showed a decrease in depressive complaints over time, while the
TABLE 1
Patient characteristics
Experimental group (n ¼ 21) Control group (n ¼ 13)
Men: n (%) 14 (67%) 10 (77%)
Age in years at baseline: mean (SD) 42.2 (15.4) 39.4 (15.6)
Time since injury in months: mean
(SD)
38.9 (42.4) 65.9 (117.1)
Education Low: n (%) 4 (19%) 4 (31%)
Intermediate: n (%) 12 (57%) 6 (46%)
High: n (%) 5 (24%) 3 (23%)
Cause of injury Stroke 7 (33%) 5 (38%)
TBI 6 (28%) 5 (38%)
Brain tumour 1 (5%) 2 (15%)
Mixed stroke/TBI 2 (10%) 1 (8%)
Other causea 5 (24%) 0 (0%)
TBI: traumatic brain injury; a Meningitis (n ¼ 1), chronic toxic encephalopathy (n ¼ 1), combi-
nation stroke and tumour (n ¼ 3). No statistically significant differences were found between the
groups on any of the variables.
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TABLE 2
Mean neuropsychological functioning at T0 and T2, including percentage of patients with a deficit
Experimental group Control group
T0 n ¼ 21 Deficita T2 n ¼ 20 Deficita T0 n ¼ 13 Deficita T2 n ¼ 12 Deficita
VVLT (words) Encoding 38.4 (12.1) 23.8% 42.0 (12.2) 19.0% 41.5 (8.7) 7.6% 44.8 (20.2) 7.6%
Delayed recall 6.4 (3.8) 47.6% 7.6 (3.9)∗ 42.8% 7.2 (3.3) 38.5% 7.9 (3.8) 30.8%
SCWT (seconds) Card III 132.7 (57.6) 42.9% 106.3 (50.6) 33.3% 147.6 (54.2) 53.8% 133.7 (43.4) 38.5%
Card III-II 54.6 (47.8) n.a. 37.3 (43.2) n.a. 68.6 (39.3) n.a. 55.7 (28.7) n.a.
CST (seconds) Part A: 1 concept 27.7 (11.1) n.a. 23.7 (7.4) n.a. 29.4 (18.2) n.a. 27.9 (9.1) n.a.
Part C: 2 concepts 46.7 (20.3) 38.1% 44.5 (19.6) 23.8% 40.5 (11.6) 30.8% 41.4 (13.3) 15.4%
Interference part C-A 19.0 (15.1) n.a. 20.1 (16.5) n.a. 11.1 (22.0) n.a. 13.5 (11.7) n.a.
LDST (digits) 90 seconds 39.2 (12.7) 61.9% 44.3 (12.7)∗∗ 38.1% 38.8 (13.0) 69.2% 41.0 (14.4) 61.5%
VVLT: Visual Verbal Learning Test; SCWT: Stroop Color Word Test; CST: Concept Shifting Test; LDST: Letter Digit Substitution Test; a , 1.5 SD below

































control group showed an increase in complaints, F(1,3) ¼ 5.24, p ¼ .032.
After correction for multiple testing (Bonferroni correction), however, a
was .0036 and this difference was no longer statistically significant.
Caregivers
Four of the 34 patients did not have an informal caregiver. Of the remaining
30 caregivers, 25 agreed to participate. Their mean age was 49.6 years (SD ¼
11.2). Eighteen caregivers were allocated to the experimental group and
seven to the control group. They were partners, parents, or siblings of the
patient. None of the caregiver outcome measures was found to differ
between the groups at T1 and T2. However, the high dropout rate (three in
the experimental group and four in the control group) meant that the
control group became too small to test statistically for between-group
differences.
Satisfaction with cognitive aid
The percentage of participants in the experimental group who chose to con-
tinue using a PDA or smartphone after the conclusion of the trial was
57.1%. Although the participants were able to buy the PEAT software at a
Figure 3. Goal Attainment Scores (GAS) pre- and post-treatment: Mean and standard error.
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TABLE 3
Mean (SD) outcome scores per study group at different time points
Experimental group Control group
T0 T1 T2 T3 T0 T1 T2 T3
Patients (n) (20) (19) (19) (10) (13) (10) (10) (9)
CFQ total 45.8 (15.2) 42.7 (15.4) 42.2 (15.9) 48.4 (10.6) 49.1 (11.2) 46.9 (20.0) 49.2 (14.8) 45.4 (15.1)
FAI total 19.3 (10.7) 21.2 (9.1) 23.0 (7.6) 25.6 (7.4) 23.4 (5.9) 22.0 (7.2) 20.9 (7.3) 24.3 (8.0)
UCL Active reaction 15.3 (4.4) 16.6 (4.1) 15.8 (4.4) 15.1 (5.8) 15.5 (2.3) 15.5 (3.3) 15.0 (3.6) 14.7 (3.7)
Palliative 16.9 (3.3) 17.3 (3.4) 17.2 (2.3) 16.2 (3.5) 18.8 (3.9) 19.3 (4.1) 19.2 (5.1) 19.2 (3.8)
Avoidance 17.3 (4.6) 16.6 (4.9) 16.9 (4.8) 17.4 (3.6) 17.6 (3.7) 17.7 (3.2) 17.3 (4.3) 19.1 (3.7)
Social support 13.6 (4.3) 13.3 (3.5) 13.3 (3.2) 12.2 (3.2) 11.6 (3.6) 11.9 (3.1) 12.4 (3.7) 12.2 (2.8)
Passive 12.7 (3.7) 12.0 (3.8) 11.9 (3.4) 12.5 (3.8) 14.5 (4.2) 15.1 (4.7) 16.4 (5.9) 15.9 (5.9)
Expression of emotions 6.5 (1.5) 5.9 (1.4) 7.1 (1.7) 7.2 (1.3) 5.9 (1.7) 6.0 (1.4) 6.3 (1.7) 6.6 (1.4)
Reassuring thoughts 11.1 (2.5) 10.8 (2.6) 11.6 (2.3) 10.8 (2.5) 10.8 (2.2) 10.7 (2.3) 10.6 (3.1) 10.8 (2.8)
CES-D 18.2 (6.3) 17.9 (7.4) 18.0 (8.9) 19.3 (7.8) 19.9 (4.9) 19.0 (5.9) 20.2 (6.2) 19.0 (7.7)
SF-36 Physical functioning 44.7 (7.7) 43.7 (10.1) 43.9 (9.9) 46.7 (8.4) 45.7 (10.2) 51.3 (8.0) 45.6 (7.2) 48.1 (12.1)
Mental functioning 38.6 (13.3) 40.1 (12.1) 39.6 (13.2) 36.9 (12.2) 35.5 (10.8) 34.8 (12.6) 34.8 (13.3) 35.5 (11.6)
GSES 26.3 (5.6) 25.3 (5.2) 25.0 (6.7) 25.9 (6.5) 26.5 (5.9) 25.1 (6.4) 25.3 (6.4) 25.2 (6.2)
LISAT-9 40.4 (7.3) 39.1 (7.5) 39.2 (6.7) 40.1 (5.3) 33.9 (8.1) 35.0 (7.8) 32.3 (7.8) 32.6 (6.1)
Caregivers (n) (18) (15) (15) (9) (7) (4) (3) (4)
CES-D 17.3 (6.9) 17.7 (7.9) 15.3 (5.9) 16.2 (5.4) 18.3 (5.8) 15.8 (2.1) 15.6 (2.0) 14.5 (3.3)
SF-36 Physical functioning 49.6 (10.8) 50.5 (11.7) 51.5 (11.6) 53.2 (10.6) 52.1 (6.0) 53.8 (10.4) 53.1 (8.8) 53.8 (6.7)
Mental functioning 43.5 (9.9) 45.0 (8.3) 44.0 (11.4) 45.1 (9.8) 46.2 (10.9) 46.3 (7.4) 42.2 (3.8) 52.1 (6.2)
LISAT-9 44.8 (6.4) 43.5 (6.4) 41.0 (5.7) 41.1 (4.4) 42.6 (3.7) 41.8 (2.4) 41.5 (0.7) 44.7 (1.5)
CSI 6.8 (3.3) 7.5 (3.2) 6.4 (3.8) 7.7 (4.1) 8.8 (3.7) 6.5 (4.9) 6.3 (5.0) 4.8 (2.6)
CFQ: Cognitive Failure Questionnaire; FAI: Frenchay Activity Index; UCL: Utrecht Coping List; CES-D: Centre for Epidemiologic Studies Depression


































90% reduced price, the main reasons for participants not to continue their use
of PEAT were that it was too expensive to buy for themselves (19.0%) or that
they preferred to use another, cheaper aid (23.8%). The software did not
operate error-free during the trial, and glitches in the software and hardware
caused frustration to some of the participants in the experimental group,
although all of these issues were dealt with within a week. Examples of
these technical difficulties were the temporary inability of the device to
recharge or to add a new task to the schedule, loss of the charging device
or unexpected (at least for the user) “change in the schedule” allegedly
caused by the software.
In the control group, the majority (76.9%) chose to continue using a paper-
and-pencil aid. However, three participants in this group (23.1%) said they
would consider buying PEAT or another PDA or smartphone system.
The difference in satisfaction rate between the experimental and control
groups was not statistically significant, x2(1, 34) ¼ 1.4, p ¼ .24.
Three participants in the experimental group stopped using PEAT after T2.
Two participants felt the PEAT training was too demanding for them and one
participant became too frustrated by the glitches in the software and hardware
to continue using the device. The per-protocol analysis of satisfaction rate
showed a higher satisfaction rate in the experimental group (66.7%) as com-
pared to the intention-to-treat analysis, while the satisfaction rate in the
control group was about the same (76.5%). The per-protocol analysis
showed no statistically significant differences in satisfaction rate between
the treatment groups, x 2(1, 34) ¼ 0.9, p ¼ .34.
DISCUSSION
This is one of the first randomised parallel-group trials to examine the
effects of using a customised PDA as a cognitive aid for patients with
acquired brain injury (ABI). Patients with ABI in both intervention
groups attained their pre-defined goals, but the success of the intervention
in the PDA group did not differ significantly from that in the paper-and-
pencil group. No effect of time or treatment group was found on the
other outcome measures.
Attainment of personal goals did not result in a higher quality of life or a
greater sense of self-efficacy. The lack of difference in effect may be related
to a number of factors, such as the small groups, the short duration of the
intervention, the low training intensity and the use of standard questionnaires.
The focus of GAS is on what participants aim to attain at a personal level, and
these goals are most likely the driving force behind their motivation to receive
cognitive training. But measuring an effect on the other outcome measures,
e.g., on quality of life, may be more difficult as these outcomes are secondary
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to a change in behaviour, and may also be influenced by factors other than the
actual treatment received in this study.
The effect of both interventions appeared to be similar, which means that
we cannot conclude that the use of a PDA was more effective than that of the
usual external devices, such as notebooks. We can only conclude that a PDA
could be considered as an equally effective alternative to standard paper-and-
pencil aids. This is nevertheless an important result in the light of our previous
finding that some professionals and caregivers believe that the use of PDAs
may not be suitable for ABI patients (De Joode et al., 2012).
The only previous randomised trial in this area of research (Wilson et al.,
2001) showed that patients using a pager were more successful in daily tasks
than the control group that did not use the device. In the current study we did
not find a significant difference in target behaviour attainment between the
experimental and control groups. However, the control group in the study
by Wilson et al. did not receive treatment (waiting list), while in the
current study the experimental intervention was compared with care-as-usual.
Recently, a report was published about the results of an eight-week con-
trolled trial studying the effect of the use of two types of PDA on the
timely completion of predefined tasks (Dowds et al., 2011). In contrast
with the present study, these authors found a significant increase in completed
tasks when a PDA was used as a reminder aid. However, the use of the PDA,
the study sample, and the duration and outcome measures were different from
those in the current study. First and foremost, patients in the study by Dowds
et al. were assisted in entering the appointments in the PDA, to make sure that
the reminder would be activated at the right time and with an audible prompt.
This is comparable to the way the Neuropage was used in a study of its effi-
cacy (Wilson, Emslie, Quirk, Evans, & Watson, 2005), in which message
prompts were programmed by others, and patients were only instructed
how to react to the prompts. In the present study, no such control was exer-
cised over the input of the reminders. This could be a reason why the use
of the PDA was less effective in our study than in the study by Dowds
et al. Furthermore, it is not clear if the samples in these studies are compar-
able, as Dowds et al. included only patients with TBI with an average to
below-average level of neuropsychological functioning. Our study included
patients with a variety of ABI aetiologies, and more than half of the subjects
were impaired regarding at least one cognitive domain.
The possible influence of age, previous experience with computers, aetiol-
ogy of brain injury and level of cognitive functioning has been described in
previous studies (Evans, Wilson, Needham, & Brentnall, 2003; Fish,
Manly, Emslie, Evans, & Wilson, 2008; Thone-Otto & Walther, 2003).
Patients of a younger age, those having more experience with computers
and those with fewer memory and executive problems are more likely to be
successful using an electronic memory aid. Less than half of the patients in
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both treatment conditions in our study had a clinically relevant memory
deficit regarding encoding or delayed recall. This raises the question
whether the use of a customised PDA would be equally effective in a more
severely affected patient sample. Unfortunately, the small sample size in
the current study made it impossible to investigate the potential moderating
effects of any patient characteristics on the effectiveness of the intervention.
Limitations
Our relatively small sample size makes it more difficult to draw solid con-
clusions and could account for the general lack of group differences over
time. Although seven centres participated in this study, overall recruitment
was poor. We suspect that this was partly due to a stringent selection of par-
ticipants by the professionals at the centres. Since research is not the first pri-
ority for most clinicians, coaching and motivating the recruiters seems
important for the successful recruitment of participants. However, practical
circumstances meant that the total duration of face-to-face contact between
the researchers and the therapists was limited, which could have affected
the inclusion and dropout rates.The dropout rate among patients was substan-
tial, which might be partly due to them moving from the rehabilitation centre
to their home situation during the intervention period, a reduced need for fre-
quent training sessions over time, or the length of the intervention period.
Perhaps the decreasing number of hours spent on cognitive rehabilitation
and the return to their “normal” daily lives also reduced their motivation to
continue their involvement in the study.
Post-hoc power analysis showed that the current sample and the statistical
methods we used allowed within/between interactions with a medium effect
size to be detected with a power of .81. In other words, an interaction effect
between treatment group and time could have been reliably detected.
However, the power to detect between-factor interactions with a medium
effect size was only .37. The power to detect a main effect of treatment
group or time was thus insufficient.
The cognitive device used in this study did not always operate as expected,
and glitches in both hardware and software could have resulted in patient
dropout or in a reduction of the potential treatment effect. Mobile technology
has evolved rapidly since we selected the device and software to be used in
this study, and it is expected that newly developed devices will be more
stable and less error-prone.
We observed that support and assistance by a caregiver could improve the
value of PDAs for individuals with ABI. Their brain injury makes them less
able to deal with unexpected responses of calendar software, and they use less
effective problem solving strategies (De Joode et al., 2011). It is therefore
important to support patients’ use of electronic cognitive aids even after the
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completion of training at a rehabilitation centre, for instance by providing
access to an online helpdesk.
Previous studies have demonstrated that a lack of efficacy of rehabilitation
interventions could be due to a response shift counteracting the effects of the
treatment (Rasquin et al., 2010). Patients may have been made more aware of
their problems by the training programme, which may have a negative effect
on their self-reported level of functioning.
Finally, the lack of blinding in the current study has to be taken into
account: the effect of the experimental intervention could have been posi-
tively biased by expectations among patients, caregivers, therapists and the
researcher about the potential superiority of a PDA over standard external
aids.
Conclusion
Our results indicate that patients seem to benefit from both PDA-based and
paper-and-pencil based cognitive aids, although the effects are restricted to
the realm of personal goals measured by GAS. The customised PDA was
shown to be as effective as paper-and-pencil aids and can therefore be con-
sidered as a useful alternative in cognitive rehabilitation. However, the finan-
cial cost of using assistive technology may still be a significant obstacle for a
large number of potential users. This financial hurdle should therefore be
overcome before assistive technology can be implemented as a part of stan-
dard care. The choice of either a digital or a paper-and-pencil cognitive aid
should be assessed for individual patients, depending on their specific
needs and capacities.
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